BGN4 & BORI 乳酸菌研究所

BIFIDO 國家級研發中心:

統籌、整合國內學術界15所 一流大學乳酸菌研發計畫

回到首頁

研發計畫:
現有執行計畫:
  • Development of allergy-suppressive Bifidobacterium and Lactobacillus.
  • Development of rotavirus-inhibiting Bifidobacterium; BORI protein, a novel rotavirus-inhibiting active component, is in pending for patent in USA, Europe, and Japan.
  • Development of tumor-suppressive Bifidobacterium; chiro-inositol containing polysaccharide, a novel tumor-suppressive active component, was characterized.
  • Development of food-grade vectors for Bifidobacterium
Major Projects
  • The effect of Gimchi intake on the microorganism in the intestine of human body.
  • Development and commercialization of the physiological active bifidus bacterium that is suitable to the Korean.
  • Development of the Bifidus fermented product for strengthening immunity function by using rice and vegetables.
  • Development of functional intestinal regulation product by using bacteriosin production lactic bacterium.
  • Development of intestinal regulation product for the elderly by using farm produces.
  • Searching examination of the immunity active factors inside the intestine that were originated from Bifidobacterium and study on their modes of actions.
  • Development of bacteriocin-producing probiotic products.
  • Development of food-grade vector for Bifidobacterium.
  • Study on food nutrient for preventing chronic disease.
  • Isolation and characterization of immno-potentiation and cancer-prevention biomaterials derived from Bifidobacterium-fermented products.
  • Development of high quality processed product by using the pleuropterus multflorus, and searching examination about generation and inhibition of oxidized form.
  • Enhancement of immunity activation originated from Bifidobacterium and development and industrialization of materials for preventing colorectal cancer Bifidobacterium .
  • Production of enzyme of CLA(conjugated linoleic acid), a physiological activation substance.
  • Development of high efficient separation and withdrawal process based on production of high functional bifidobacterium.
  • Development of the delivery system inside the intestine by using bifidus, and expression of the anti-rotavirus protein.
  • Development and industrialization of high functional soybean fermented food by using Rhizopus and Monascus.
  • Development of the allergy lowering probiotics product.
  • Development of functional food based on bifidus that produces chiro-inositol polysaccharose.
  • Tablet formulation and development of product, of anti-rota virus active bifidus and protein(BORI)
  • Production of high density bifdobacterium by using the next generations high performance bioreactor and development of technologies for bio-conversion of ginseng extracts.
  • Development of the fine vasculature blood circulation improved product by using bio conversion ginseng.
  • Industrialization by using Bifidus that produces anti-bacteria active substance.
  • Development of functional food based on bifidus that produces cairo-inositol polysaccharose..
  • Development of probiotics bacteria that lower sensitive storage, and study on converting them into products.
  • Development of difficult-to-expression recombination proteolytic enzyme by using the culture of plant cells.

回到首頁